bilaterals.org logo
bilaterals.org logo

intellectual property


12 reasons why we say NO to the Mercosur – European Union free trade agreement
We invite you to add your signatures to this document.
Tokyo’s drift towards intellectual property crusader
Japan’s role in RCEP negotiations appears to have been shaped by its participation in the TPP. Japan is now championing for expanded intellectual property right provisions which may block access to affordable medicines
NAFTA will undermine health unless Canada resists monopolies on medicines
Time and again, Canadians reaffirm their belief in the basic principle of equitable access to health care for all. But the spirit of this very Canadian principle remains in peril as NAFTA negotiations forge ahead.
RCEP talks in Indonesia focus on concessions, crafting of sensitive list
As the Trans-Pacific Partnership (TPP) made significant headway in January, negotiating countries in the Regional Comprehensive Economic Partnership (RCEP) are pressured to conclude the trade deal, and they try to make progress in the ongoing talks in Indonesia.
Delhi’s RCEP talks on intellectual property shouldn’t forget India’s role as ‘Pharmacy of the World’
India must resist pressure from Japan and South Korea in RCEP for the elevated levels of intellectual property provisions and make sure the deal doesn’t limit the production of life-saving generic drugs in India and for many other developing countries of the world.
Over 100 organizations concerned with health sign open letter to Canadian, Mexican and US ministers of health and trade
AIDS, cancer, religious-based, teacher, and retiree advocacy groups were among the more than 100 organizations that recently signed a letter warning health and trade ministers of the United States, Canada, and Mexico not to undermine NAFTA’s access to affordable medicines.
Israel set to make a strong push for goods FTA
The present Indian government has relaunched the talks with Israel. Israel wishes to conduct talks on regular basis to conclude the deal at the earliest. Indian patent system and pharmaceutical related issues have been the reasons why the deal couldn’t progress.
Risks for agriculture in developing countries of new e-commerce rules
Reliance on digital technologies can further concentrate the market dominance of vertically integrated agribusinesses and transnational corporations who control national and global supply chains.
RCEP: India in a Catch-22
India’s position in the RCEP is the most protectionist among all the member nations. India has been resisting demands from Korea & Japan on intellectual property clauses, and other nations on opening up markets.
2018: A year of uncertainty for international intellectual property
The US government’s role as a leader of the international intellectual property system is under self-imposed threat.
India, South Korea may hold joint IPRs through trade pact
South Korean and India plan to jointly hold intellectual property rights (IPRs) in areas of manufacturing, energy and healthcare, as part of the negotiations for the bilateral trade agreement that the two countries recently reviewed
EU-Mercosur trade agreement: A bad deal for transparency, policy coherence and access to medicines
Negotiations are now nearing completion and there are increasing concerns among public health advocates, patient and consumer organisations, and other stakeholders, both in Europe and the Americas.
Intellectual property rights in trade – to be rethought?
After two decades of intellectual property regimes in trade agreements, one could have some second thoughts.
What the European-Union Mercosur trade agreement means for copyright
Many of the intellectual property provisions raised by the European Union in this agreement are bad for internet users.
Trade agreements that impact seed laws in Africa
Free trade agreements represent a powerful source of pressure to privatise seeds and people’s knowledge connected to seeds.
EU-Mercosur FTA: draft chapters (July 2017)
8 draft chapters, as leaked by Greenpeace
South Centre statement on EU-MERCOSUR trade negotiations
EU-MERCOSUR trade negotiations must not impose TRIPS Plus provisions on protection and enforcement of intellectual property rights.
EU-Mercosur FTA puts at risk access to medicines in Brazil, new impact assessment study finds
The adoption of the measures proposed by the EU could put the sustainability of access to health policies in Brazil at risk, as they could sharply increase public expenditures on medicines.